<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive License: The Development of Modified T-cells for the Treatment of Multiple Myeloma</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive License: The Development of Modified T-cells for the Treatment of Multiple Myeloma</h1>
    <p class="timestamp">Published: 2013-11-19 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209 and 37 CFR Part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant to Thirsty Brook Bioscience, Inc., of an exclusive evaluation option license to practice the inventions embodied in the following US Patent Applications (and all continuing applications and foreign counterparts): Serial No. 61/ 622,6008 entitled, "Chimeric Antigen Receptors Targeting B-cell Maturation Antigen" [HHS Ref. ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2013-27601</p>
    <p><strong>Publication Date:</strong> 2013-11-19</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/11/19/2013-27601/prospective-grant-of-exclusive-license-the-development-of-modified-t-cells-for-the-treatment-of">https://www.federalregister.gov/documents/2013/11/19/2013-27601/prospective-grant-of-exclusive-license-the-development-of-modified-t-cells-for-the-treatment-of</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-27601</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
